How seriously are in stitutional shareholders taking corporate social responsibility? Is it mere tokenism?
No takes yet. Share an insight, caveat, or question.
Solomon et al. (2002) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: